Results: 1-25 | 26-42
Results: 1-25/42

Authors: Wuchter, C Krappmann, D Cai, Z Ruppert, V Scheidereit, C Dorken, B Ludwig, WD Karawajew, L
Citation: C. Wuchter et al., In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cellsin the context of TRAIL receptor gene expression and constitutive NF-kappaB activity, LEUKEMIA, 15(6), 2001, pp. 921-928

Authors: Cai, Z Lin, M Wuchter, C Ruppert, V Dorken, B Ludwig, WD Karawajew, L
Citation: Z. Cai et al., Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation, LEUKEMIA, 15(4), 2001, pp. 567-574

Authors: Wuchter, C Ratei, R Spahn, G Schoch, C Harbott, J Schnittger, S Haferlach, T Creutzig, U Sperling, C Karawajew, L Ludwig, WD
Citation: C. Wuchter et al., Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping, HAEMATOLOG, 86(2), 2001, pp. 154-161

Authors: Martin-Subero, JI Siebert, R Harder, L Gesk, S Schwindt, P Brauninger, A Willenbrock, K Steinemann, D Tiemann, M Calasanz, MJ Grote, W Ludwig, WD Hansmann, ML Schlegelberger, B
Citation: Ji. Martin-subero et al., Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphoma, AM J HEMAT, 68(4), 2001, pp. 276-279

Authors: Buchner, T Hiddemann, W Berdel, W Wormann, B Loffler, H Schoch, C Haferlach, T Ludwig, WD Maschmeyer, G Staib, P Andreesen, R Balleisen, L Haase, D Eimermacher, H Aul, C Rasche, H Uhlig, J Gruneisen, A Reis, HE Hartlapp, J Hirschmann, WD Weh, HJ Pielken, HJ Gassmann, W Sauerland, MC Heinecke, A
Citation: T. Buchner et al., Remission induction therapy: the more intensive the better?, CANC CHEMOT, 48, 2001, pp. S41-S44

Authors: Fuchs, U Rehkamp, G Haas, OA Slany, R Konig, M Bojesen, S Bohle, RM Damm-Welk, C Ludwig, WD Harbott, J Borkhardt, A
Citation: U. Fuchs et al., The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia, P NAS US, 98(15), 2001, pp. 8756-8761

Authors: Bene, MC Bernier, M Casasnovas, RO Castoldi, G Doekharan, D van der Holt, B Knapp, W Lemez, P Ludwig, WD Matutes, E Orfao, A Schoch, C Sperling, C van't Veer, MB
Citation: Mc. Bene et al., Acute myeloid leukaemia MO: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients, BR J HAEM, 113(3), 2001, pp. 737-745

Authors: Hilgenfeld, E Padilla-Nash, H McNeil, N Knutsen, T Montagna, C Tchinda, J Horst, J Ludwig, WD Serve, H Buchner, T Berdel, WE Schrock, E Ried, T
Citation: E. Hilgenfeld et al., Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2, BR J HAEM, 113(2), 2001, pp. 305-317

Authors: Dreyling, MH Schrader, K Muschinsky, V Fonatsch, C Schlegelberger, B Haase, D Schoch, C Ludwig, WD Hiddemann, W Bohlander, SK
Citation: Mh. Dreyling et al., Molecular characterization of the translocation (10;11)(p13;q14): MLL and CALM are fused to AF10 in morphologically different subsets of acute leukemia, HEMAT BLOOD, 40, 2001, pp. 20-26

Authors: Ruppert, V Wuchter, C Dorken, B Ludwig, WD Karawajew, L
Citation: V. Ruppert et al., Involvement of BCL-2 and Bax in the IL-3-induced inhibition of spontaneousapoptosis in childhood T-ALL, HEMAT BLOOD, 40, 2001, pp. 128-135

Authors: Kern, W Matylis, A Gruneisen, T Huber, C Grote-Metke, A Wormann, B Buchner, T Ohnesorge, J Ludwig, WD Hiddemann, W
Citation: W. Kern et al., Modulation of AraC by fludarabine: Results of salvage therapy by AMLCG, HEMAT BLOOD, 40, 2001, pp. 201-209

Authors: Kern, W Matylis, A Gruneisen, T Huber, C Grote-Metke, A Wormann, B Buchner, T Ohnesorge, J Ludwig, WD Hiddemann, W
Citation: W. Kern et al., Randomized comparison of sequential high-dose cytosine arabinoside and idarubicin (S-HAI) with or without chemo-modulation by fludarabine in refractory and relapsed acute myeloid leukemia, HEMAT BLOOD, 40, 2001, pp. 578-587

Authors: Burger, R Gerlich, W Gurtler, L Heiden, M Hitzler, W Jansen, B Lefevre, H Lower, J Ludwig, WD Montag-Lessing, T Paessens, A Pauli, G Seitz, R Schlenkrich, U Werner, E Willkommen, H
Citation: R. Burger et al., TT virus, INFUS THER, 27(3), 2000, pp. 114-116

Authors: Ratei, R Matylis, A Krahl, D Arnold, R Stein, H Dorken, B Ludwig, WD
Citation: R. Ratei et al., Salvage therapy for relapsed mediastinal B-cell lymphoma with allogeneic HLA-identical related donor bone marrow transplantation, donor lymphocyte infusion and IDEC-C2B8, LEUK LYMPH, 40(1-2), 2000, pp. 133-140

Authors: Buchner, T Hiddemann, W Wormann, B Loffler, H Ludwig, WD Schoch, C Haferlach, T Maschmeyer, G Staib, P Aul, C Heyll, A Gruneisen, A Rasche, H Eimermacher, H Balleisen, L Pielken, HJ Reis, HE Griesinger, F Reichle, A Sauerland, MC Heinecke, A
Citation: T. Buchner et al., Acute myeloid leukemia in adults: Is postconsolidation maintenance therapynecessary?, INT J HEMAT, 72(3), 2000, pp. 285-289

Authors: Gokbuget, N Hoelzer, D Arnold, R Bohme, A Bartram, CR Freund, M Ganser, A Kneba, M Langer, W Lipp, T Ludwig, WD Maschmeyer, G Rieder, H Thiel, E Weiss, A Messerer, D
Citation: N. Gokbuget et al., Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL), HEMAT ONCOL, 14(6), 2000, pp. 1307

Authors: Prokop, A Wieder, T Sturm, I Essmann, E Seeger, K Wuchter, C Ludwig, WD Henze, G Dorken, B Daniel, PT
Citation: A. Prokop et al., Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo, LEUKEMIA, 14(9), 2000, pp. 1606-1613

Authors: Lengfelder, E Reichert, A Schoch, C Haase, D Haferlach, T Loffler, H Staib, P Heyll, A Seifarth, W Saussele, S Fonatsch, C Gassmann, W Ludwig, WD Hochhaus, A Beelen, D Aul, C Sauerland, MC Heinecke, A Hehlmann, R Wormann, B Hiddemann, W Buchner, T
Citation: E. Lengfelder et al., Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia, LEUKEMIA, 14(8), 2000, pp. 1362-1370

Authors: Wuchter, C Harbott, J Schoch, C Schnittger, S Borkhardt, A Karawajew, L Ratei, R Ruppert, V Haferlach, T Creutzig, U Dorken, B Ludwig, WD
Citation: C. Wuchter et al., Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1, LEUKEMIA, 14(7), 2000, pp. 1232-1238

Authors: Kordes, U Krappmann, D Heissmeyer, V Ludwig, WD Scheidereit, C
Citation: U. Kordes et al., Transcription factor NF-kappa B is constitutively activated in acute lymphoblastic leukemia cells, LEUKEMIA, 14(3), 2000, pp. 399-402

Authors: Stanulla, M Kasper, B Schrappe, M Viehmann, S Harbott, J Ludwig, WD Welte, K
Citation: M. Stanulla et al., Granulocyte colony-stimulating factor receptor expression and 11q23/MLL genotype in childhood acute lymphoblastic leukemia developing during the first 18 months of life, LEUKEMIA, 14(2), 2000, pp. 337-338

Authors: Schrappe, M Reiter, A Zimmermann, M Harbott, J Ludwig, WD Henze, G Gadner, H Odenwald, E Riehm, H
Citation: M. Schrappe et al., Long-term results of four consecutive trials in childhood ALL performed bythe ALL-BFM study group from 1981 to 1995, LEUKEMIA, 14(12), 2000, pp. 2205-2222

Authors: Bohlander, SK Muschinsky, V Schrader, K Siebert, R Schlegelberger, B Harder, L Schemmel, V Fonatsch, C Ludwig, WD Hiddemann, W Dreyling, MH
Citation: Sk. Bohlander et al., Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients, LEUKEMIA, 14(1), 2000, pp. 93-99

Authors: Wuchter, C Karawajew, L Ruppert, V Schrappe, M Buchner, T Schoch, C Haferlach, T Harbott, JN Ratei, R Dorken, B Ludwig, WD
Citation: C. Wuchter et al., Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia, HAEMATOLOG, 85(7), 2000, pp. 711-721

Authors: Neth, O Seidemann, K Jansen, P Mann, G Tiemann, M Ludwig, WD Riehm, H Reiter, A
Citation: O. Neth et al., Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: Clinical features, treatment, and results in trials NHL-BFM 86 and 90, MED PED ONC, 35(1), 2000, pp. 20-27
Risultati: 1-25 | 26-42